Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control

Journal of Asthma

Volumn 48, Issue 9, 2011, Pages 914-922

  Armour, Carol L ^a,b   Lemay, Kate ^a   Saini, Bandana ^a   Reddel, Helen K ^a   Bosnic Anticevich, Sinthia Z ^a   Smith, Lorraine D ^a   Burton, Deborah ^c   Song, Yun Ju Christine ^a   Alles, Marie Chehani ^a   Stewart, Kay ^d   Emmerton, Lynne ^e,f   Krass, Ines ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c CHARLES STURT UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f CURTIN UNIVERSITY   (Australia)

Author keywords

Asthma; Australia; Community pharmacy; Pharmacist; Poor asthma control

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUTICASONE; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BRIEF MEDICATION QUESTIONNAIRE; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE CONTROL; FEMALE; FORCED VITAL CAPACITY; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL HISTORY; METERED DOSE INHALER; NEBULIZATION; ONSET AGE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHARMACIST; PHARMACY; POPULATION RESEARCH; PROSPECTIVE STUDY; QUESTIONNAIRE; RESPIROMETRY; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SYMPTOM; TREATMENT PLANNING;

ASTHMA; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 80054915382     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2011.615431     Document Type: Article

References (37)

1. Australian Centre for Asthma Monitoring. Asthma in Australia 2008. AIHW Asthma Series no. 3. Cat. No. ACM 14. Canberra: AIHW; c2008
2. Simpson CR, Sheikh A. Trends in the epidemiology of asthma in England: a national study of 333,294 patients. J R Soc Med 2010; 103(3):98-106
3. American Academy of Asthma, Allergy & Immunology. Available at http://www.aaaai.org/media/statistics/asthma-statistics.asp (accessed 5 August, 2011)
4. Rabe K, Vermeire P, Soriano J, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16:802-807
5. Marks G, Abramson M, Jenkins C, Kenny P, Mellis CM, Ruffin RE, Stosic R, Toelle BG, Wilson DH, Xuan W. Asthma management and outcomes in Australia: a nation-wide telephone interview survey. Respirology 2007; 12:212-219
6. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000; 117:542-550
7. Schafheutle E. The impact of prescription charges on asthma patients is uneven and unpredictable: evidence from qualitative interviews. Prim Care Respir J 2009; 18(4):266-272
8. Federman AD, Wisnivesky JP, Wolf MS, Leventhal H, Halm EA. Inadequate health literacy is associated with suboptimal health beliefs in older asthmatics. J Asthma 2010; 47(6):620-626
9. Basheti I, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol 2007; 119(6):1537-1538
10. Bosnic-Anticevich SZ, Sinha H, So S, Reddel HK. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma 2010; 47:251-256
11. Pinnock H, Thomas M, Tsiligianni I, Lisspers K, Ostrem A, Stallberg B,Yusuf O, Ryan D, Buffels J, Cals JWL, Chavannes NH, Henrichsen SH, Langhammer A, Latysheva E, Lionis C, Litt J, Van der Molen T, Zwar N,Williams S. The International Primary Care Respiratory Group (IPCRG) Research Needs statement 2010. Prim Care Respir J 2010; 19(Suppl 1):S1-20
12. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax. [Supplement]. 2008; 63(Suppl 4):vi1-iv121
13. Doboszynska A, Swietlik E. Asthma management at primary care level: symptoms and treatment of 3305 patients with asthma diagnosed by a family physician. J Physiol Pharmacol [Supplement]. 2008; 59 (Suppl 6):231-241
14. Boulet L-P. Improving knowledge transfer on chronic respiratory disease: a Canadian perspective. How to translate recent advances in respiratory diseases into day-to-day carem. J Nutr Health Aging 2008; 12(10):758S-763S
15. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, Saini B, Smith L, Stewart K. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62:496-502
16. Benavides S, Rodriguez J, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother [Review]. 2009; 43(1):85-97
17. Bereznicki B, Peterson G, Jackson S, Walters EH, Fitzmaurice KD, Gee PR. Data-mining of medication records to improve asthma management. Med J Aust 2008; 189(1):21-25
18. Wong MD,Manley RT, Stettin G, Chen W, Salmun LM. Intervention to reduce unnecessary dispensing of short-acting beta-agonists in patients with asthma. Ann Pharmacother 2010; 44(4):623-629
19. Unwin D, Jones K, Hargreaves C, Gray J, Eden Valley General Practice Research Group. Using a revised asthma morbidity index to identify varying patterns of morbidity in UK general practices. Respir Med 2001; 95(12):1006-1011
20. National Asthma Council Australia. Asthma Management Handbook 2006. Melbourne: NAC; c2006
21. Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005; 26(2):319-338
22. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999; 37:113-124
23. Respiratory Expert Group. Therapeutic guidelines: Respiratory. Version 4. Melbourne: Therapeutic Guidelines Limited; c2009
24. Barton C, Proudfoot J, Amoroso C, Ramsay E, Holton C, Bubner T, Harris M, Beilby J. Management of asthma in Australian general practice: care is still not in line with clinical practice guidelines. Prim Care Respir J 2009; 18(2):100-105
25. Rand C, Wise R. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. [Supplement]. 1994; 149:S69-S76
26. Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Resp Crit Care Med 2009; 180:817-822
27. Park J, Jackson J, Skinner E, Ranghell K, Saiers J, Cherney B. Impact of an adherence intervention program on medication adherence barriers, asthma control, and productivity/daily activities in patients with asthma. J Asthma 2010; 47(10):1071-1077
28. Armour CL, Smith LD, Krass I. Community pharmacy, disease state management, and adherence to medication: a review. Dis Manage Health Outcomes 2008; 16(4):245-254
29. Ampon RD, Reddel HK, Correll PK, Poulos LM, Marks GB. Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease. Med J Aust 2009; 191(6):319-323
30. Peterson GM, Jackson SL, Hughes JD, Fitzmaurice KD, Murphy LE. Public perceptions of the role of Australian pharmacists in cardiovascular disease. J Clin Pharm Ther. 2010; 35:671-677
31. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for valuation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006; 15:565-574
32. Krass I, Taylor SJ, Smith LD, Armour CL. Impact on medication use and adherence of Australian Pharmacistss diabetes care services. J Am Pharm Assoc 2005; 45:33-40
33. Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns 2008; 72: 26-33
34. McLeish A, Zvolensky M. Asthma and cigarette smoking: a review of the empirical literature. J Asthma 2010; 47:345-361
35. OByrne PM, Reddel HK, Colice GL. Does the current stepwise approach to asthma pharmacotherapy encourage over-treatment. Respirology 2010; 15: 596-602
36. Burton M, Burton D, Simpson M, Gissing PM, Bowman SL. Respiratory function testing: the impact of respiratory scientists on the training and support of health care providers. Respirology 2004; 9(2):260-264
37. Thomas M, Kay S, Pike J, Williams A, Carranza Rosenzweig JR, Hillyer EV, Price D. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Resp J 2009; 18(1):41-49